Stevens Capital Management’s Exact Sciences EXAS Stock Holding History

Stevens Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,327	Closed	-$1.11M	–	662
2019 Q3	$1.11M	Buy	+12,327	New	+$1.4M	0.1%	213
2019 Q2	–	Sell	-23,342	Closed	-$2.02M	–	697
2019 Q1	$2.02M	Buy	23,342 +11,108	+91%	+$945K	0.09%	270
2018 Q4	$772K	Buy	+12,234	New	+$840K	0.04%	430
2018 Q2	–	Sell	-43,422	Closed	-$1.75M	–	839
2018 Q1	$1.75M	Buy	43,422 +941	+2%	+$45.9K	0.07%	314
2017 Q4	$2.23M	Buy	+42,481	New	+$2.27M	0.09%	280
2014 Q1	–	Sell	-10,194	Closed	-$120K	–	1139
2013 Q4	$120K	Sell	10,194 -36,848	-78%	-$423K	﹤0.01%	960
2013 Q3	$555K	Buy	+47,042	New	+$604K	0.02%	614

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Stevens Capital Management's EXAS Position: Q4 2019 in Review

Stevens Capital Management sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 12,327 shares — an estimated $1.11M sold.

Stevens Capital Management first reported a position in EXAS in Q3 2013 and held it in 7 quarters. The position peaked at $2.23M in Q4 2017. 526 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

Stevens Capital Management reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
Stevens Capital Management sold 12,327 Exact Sciences shares in Q4 2019, an estimated $1.11M.
Stevens Capital Management first reported a position in Exact Sciences in Q3 2013 and held it in 7 quarters.
Stevens Capital Management's Exact Sciences position peaked at $2.23M in Q4 2017.
526 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Stevens Capital Management's 13F filing for Q4 2019, filed 6 Feb 2020.